BiotechTube
Home/Olatec Therapeutics/Charles A. Dinarello, MD
CA

Charles A. Dinarello, MD

Chairman of SAB, co-Chief Scientific Officer

Olatec Therapeutics

Therapeutic Areas

Inflammatory DiseasesArthritisCardiovascularNeurologyOncologyMetabolic Diseases

Olatec Therapeutics Pipeline

DrugIndicationPhase
Dapansutrile (OLT1177®)Broad spectrum of NLRP3-mediated inflammatory diseases (e.g., Arthritis, Heart Failure, Neurodegenerative)Phase 2

Leadership Team at Olatec Therapeutics

DB
Damaris B. Skouras
Founder, Chairman, Chief Executive Officer
View full Olatec Therapeutics profile